A Study of STI-3031 (an Anti-PD-L1 Antibody) in Patients With Selected Relapsed/Refractory Malignancies
Sorrento Therapeutics, Inc.
Sorrento Therapeutics, Inc.
University of California, San Diego
University of Texas Southwestern Medical Center
Rutgers, The State University of New Jersey